Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19： a meta-analysis
W Wen, C Chen, J Tang, C Wang, M Zhou… - Annals of …, 2022 - Taylor & Francis
Background The coronavirus disease (COVID-19) epidemic has not been completely
controlled. Although great achievements have been made in COVID-19 research and many …
controlled. Although great achievements have been made in COVID-19 research and many …
Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection
V Ruggiero, RP Aquino, P Del Gaudio, P Campiglia… - Pharmaceutics, 2022 - mdpi.com
Post-COVID syndrome or long COVID is defined as the persistence of symptoms after
confirmed SARS-CoV-2 infection, the pathogen responsible for coronavirus disease. The …
confirmed SARS-CoV-2 infection, the pathogen responsible for coronavirus disease. The …
[HTML][HTML] Efficacy and safety of molnupiravir for COVID-19 patients
The Coronavirus Disease 2019 (COVID-19) continues to be a major source of morbidity and
mortality across the globe. Current medical therapy against COVID-19 includes drugs that …
mortality across the globe. Current medical therapy against COVID-19 includes drugs that …
Pandemic COVID-19, an update of current status and new therapeutic strategies
A Vitiello, R La Porta, U Trama, F Ferrara, A Zovi… - Naunyn-Schmiedeberg's …, 2022 - Springer
The global COVID-19 pandemic is underway. In recent weeks, several countries throughout
the globe, and particularly in Europe, have experienced an exponential increase in the …
the globe, and particularly in Europe, have experienced an exponential increase in the …
Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic
Despite the progress in the management of COVID-19, effective oral antiviral agents are still
lacking. In the present review, the potential beneficial effects of molnupiravir in the …
lacking. In the present review, the potential beneficial effects of molnupiravir in the …
In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2
M Shah, R Yamin, I Ahmad, G Wu, Z Jahangir… - Plos one, 2024 - journals.plos.org
Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) is the causative agent of
COVID-19 pandemic, which has resulted in global fatalities since late December 2019 …
COVID-19 pandemic, which has resulted in global fatalities since late December 2019 …
Use of oral antivirals ritonavir-nirmatrelvir and molnupiravir in patients with multiple myeloma is associated with low rates of severe COVID-19: a single-center …
V Spiliopoulou, I Ntanasis-Stathopoulos, P Malandrakis… - Viruses, 2023 - mdpi.com
In patients with multiple myeloma (MM), SARS-CoV-2 infection has been associated with a
severe clinical course and high mortality rates due to the concomitant disease-and treatment …
severe clinical course and high mortality rates due to the concomitant disease-and treatment …
Outpatient treatment options to address the SARS-CoV-2 variant Omicron
MW McCarthy - Expert Review of Anti-infective Therapy, 2022 - Taylor & Francis
ABSTRACT Introduction On 26 November 2021, the World Health Organization's Technical
Advisory Group on SARS-CoV-2 Virus Evolution designated PANGO lineage B. 1.1. 529 a …
Advisory Group on SARS-CoV-2 Virus Evolution designated PANGO lineage B. 1.1. 529 a …
Emerging small molecule antivirals may fit neatly into COVID-19 treatment
C Fenton, SJ Keam - Drugs & Therapy Perspectives, 2022 - Springer
Numerous treatments exist for COVID-19, the illness caused by SARS-CoV-2 virus, although
most are not well established; among these are several small molecule antiviral agents …
most are not well established; among these are several small molecule antiviral agents …
Phenothiazines inhibit SARS-CoV-2 entry through targeting spike protein
T Liang, S Xiao, Z Wu, X Lv, S Liu, M Hu, G Li, P Li… - Viruses, 2023 - mdpi.com
Novel coronavirus disease 2019 (COVID-19), a respiratory disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought an unprecedented public …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought an unprecedented public …